IRIS
CAPULLI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.769
EU - Europa 1.109
AS - Asia 506
SA - Sud America 2
OC - Oceania 1
Totale 3.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.766
IE - Irlanda 332
CN - Cina 278
TR - Turchia 186
DE - Germania 167
SE - Svezia 151
IT - Italia 127
UA - Ucraina 115
GB - Regno Unito 102
FI - Finlandia 47
FR - Francia 43
SG - Singapore 17
VN - Vietnam 12
BE - Belgio 10
IN - India 6
CZ - Repubblica Ceca 5
RU - Federazione Russa 4
NL - Olanda 3
BR - Brasile 2
CA - Canada 2
JP - Giappone 2
KR - Corea 2
AU - Australia 1
CH - Svizzera 1
IL - Israele 1
KZ - Kazakistan 1
MX - Messico 1
PL - Polonia 1
RO - Romania 1
TH - Thailandia 1
Totale 3.387
Salva come PNG Salva come JPEG
Città #
Jacksonville 446
Chandler 375
Dublin 332
Boardman 101
Izmir 99
Nanjing 91
San Mateo 77
Ann Arbor 63
Lawrence 59
Princeton 59
Wilmington 56
Ashburn 53
New York 36
L'aquila 35
Milan 32
Nanchang 29
Woodbridge 26
Bremen 25
Beijing 23
Seattle 21
Kitzingen 20
Shenyang 18
Tianjin 18
Guangzhou 17
Dearborn 12
Dong Ket 12
Singapore 11
Verona 11
Brussels 10
Hebei 10
Jinan 10
Mountain View 10
Norwalk 10
Des Moines 9
Kunming 8
Jiaxing 7
L’Aquila 7
Washington 6
Aquila 5
Dallas 5
Falls Church 5
Lanzhou 5
Los Angeles 5
Shanghai 5
Brno 4
Fremont 4
Ningbo 4
Redmond 4
Shangdi 4
Strasbourg 4
Zhengzhou 4
Changchun 3
Changsha 3
Pune 3
Auburn Hills 2
Fairfield 2
Fuzhou 2
Harbin 2
Houston 2
Munich 2
Nerviano 2
Pisa 2
Regensburg 2
Rome 2
Sumter 2
Taizhou 2
Torre Del Greco 2
West Jordan 2
Almaty 1
Amsterdam 1
Bangkok 1
Baotou 1
Bellante 1
Cedar Knolls 1
Chicago 1
Cividate al Piano 1
Edinburgh 1
Galliate 1
Grafing 1
Guiyang 1
Haikou 1
Hangzhou 1
Hanover 1
Helsinki 1
Hitzkirch 1
Lanciano 1
Leipzig 1
London 1
Martino 1
Mesa 1
Mexico 1
Montréal 1
Morvi 1
Moscow 1
Orange 1
Osaka 1
Pescara 1
Piekary Slaskie 1
Pogno 1
Recife 1
Totale 2.371
Salva come PNG Salva come JPEG
Nome #
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 103
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 98
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 92
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 81
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 79
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 79
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 78
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 76
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 75
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 75
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 75
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 74
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 74
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 71
Non-conventional role of haemoglobin beta in breast malignancy 70
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 69
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. 67
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 67
the effect of microgravity on osteoblast metabolism 66
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 64
c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation 63
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 61
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity 60
ENERGY METABOLISM OF PROSTATE CANCER CAN BE SUPPORTED BY REVERSE WARBURG EFFECT 57
EFFECTS OF DUAL PI3K AND mTOR INHIBITION ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 55
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 54
Lipocalin 2 is a novel mechanoresponding gene involved in osteoblast differentiation and osteoblast-osteoclast cross-talk 54
EFFECTS OF 1D11 AN ANTIBODY AGAINST TRANSFORMING GROWTH FACTOR BETA (TGF-B) ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 53
Generation and culture of osteoclasts. 53
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 53
Gene microarray analysis in mouse osteoblasts reveals sets of relevant mrnas regulated under modeled microgravity 52
Osteoblast and osteocyte: games without frontiers 51
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 51
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice 51
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 51
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 50
Role of RAMP2 and BSP2 in the c-Src-regulated osteomimicry of breast cancer bone metastasis 49
Microarray Analysis of Human Bone Metastases Evidenced a Set of Genes that Segregates Patients with Metastases only in Bone from Patients with Metastases also in Visceral Organs 48
Pre-clinical employment of the heparin binding domain of PRELP in the treatment of bone loss diseases 48
NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains 48
Systemic and local determinants contribute to the bone phenotype in duchenne muscular dystrophy 47
Mechanisms inducing low bone density in Duchenne Muscular Dystrophy 46
Lipocalin2 is a new regulator of osteoblast functions in response to mechanical forces 46
The Matrix PRoline/arginine-rich End Leucine-rich Repeat Protein (PRELP) Interferes with the NF-kappaB Pathway and Impairs Osteoclast Formation and Activity 46
Sets of genes are regulated in osteoblasts by modelled microgravity 46
Global Transcriptome Analysis in Mouse Osteoblasts Identifies a Mechanosensing Osteoblast Gene Signature 46
Osteoblasts Regulate Angiogenesis in Response to Mechanical Unloading 46
The molecular switch NHERF1 induces tumour phenotypic changes associated with distinct metastatic organotropism in breast cancer via its PDZ domains 45
Up-regulation of a set of genes in breast cancer bone metastases discloses predisposition to generate metastases also in visceral organs 45
Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss 45
A new therapeutic approach to prevent oestrogen-withdrawal induced bone loss 44
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 44
Mechanisms underlying low bone density in muscular dystrophy 42
MECHANISMS INDUCING LOW BONE DENSITY IN DUCHENNE MUSCULAR DYSTROPHY 41
Mechanisms Inducing Low Bone Density in Duchenne Muscular Dystrophy in Mice and Humans 39
Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis 36
CRELD2 Is a Novel LRP1 Chaperone That Regulates Noncanonical WNT Signaling in Skeletal Development 35
NHERF1 programs invasive and metastatic behaviours in breast tumor cells 33
Regulation of breast cancer induced bone disease by cancer-specific IKKβ 33
Multidisciplinary investigation of an ancient renal stone in a mummy from Popoli, central Italy 25
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 11
A neuronal action of sirtuin 1 suppresses bone mass in young and aging mice 10
Totale 3.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.820
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.820
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020406 0 7 55 5 1 93 95 2 60 15 4 69
2020/2021506 15 66 0 64 61 15 65 3 60 23 106 28
2021/2022325 19 30 63 22 15 4 10 16 17 8 33 88
2022/20231.029 74 55 12 125 121 111 1 62 419 6 29 14
2023/2024283 33 20 24 40 25 66 0 17 1 4 4 49
2024/202529 14 15 0 0 0 0 0 0 0 0 0 0
Totale 3.446